Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Kanazawa University started in 1862 as a smallpox vaccination centre. It is now making its mark through world-leading advances in nanotechnology, human health, environmental sciences and other fields.
The Nano Life Science Institute (NanoLSI) at Kanazawa University is recruiting postdoctoral researchers for a place at the forefront of the nanobiosciences.
The old paradigm of giving the same drug to all patients is being supplanted by a new one that includes co-opting individual patients’ own cells to fight disease. Researchers at Kanazawa Medical University are spearheading the era of personalized medicine by developing treatments that harness the power of immune cells and stem cells.
Shibuya Corporation is promoting the industrialization of regenerative medicine and contributing to society through its aseptic and automated technologies
